상품명칭 |
Nabazenil |
별명 |
Nabazenil [USAN:INN]; 1H-Azepine-1-butanoic acid, hexahydro-, 3-(1,2-dimethylheptyl)-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo(b,d)pyran-1-yl ester; 3-(1,2-Dimethylheptyl)-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo(b,d)pyran-1-yl hexahydro-1H-azepine-1-butyrate; 3-(1,2-Dimethylheptyl)-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo(b,d)pyran-1-ylhexahydro-1H-azepine-1-butyrate; 3-(11-Dimethylheptyl)-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo(b,d)pyran-1-yl 4-(1-azepanyl)butyrat; Nabazenilum; SP 175; UNII-N1RX70K36C; 6,6,9-trimethyl-3-(3-methyloctan-2-yl)-7,8,9,10-tetrahydro-6H-benzo[c]chromen-1-yl 4-(azepan-1-yl)butanoate |
분자식 |
C35H55NO3 |
분자량 |
537.8161 |
InChI |
InChI=1/C35H55NO3/c1-7-8-11-15-26(3)27(4)28-23-31(38-33(37)16-14-21-36-19-12-9-10-13-20-36)34-29-22-25(2)17-18-30(29)35(5,6)39-32(34)24-28/h23-27H,7-22H2,1-6H3 |
cas번호 |
58019-65-1 |
분자 구조 |
|
밀도 |
1.04g/cm3 |
비등점 |
624°C at 760 mmHg |
굴절 지수 |
1.541 |
인화점 |
331.2°C |
위험성 표시 |
|
리스크 규칙 |
|
보안 규칙 |
|
|